BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30758996)

  • 1. The HECT ubiquitin E3 ligase Smurf2 degrades μ-opioid receptor 1 in the ubiquitin-proteasome system in lung epithelial cells.
    Dong S; Liu J; Li L; Wang H; Ma H; Zhao Y; Zhao J
    Am J Physiol Cell Physiol; 2019 May; 316(5):C632-C640. PubMed ID: 30758996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
    Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
    Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine.
    Bailey CP; Couch D; Johnson E; Griffiths K; Kelly E; Henderson G
    J Neurosci; 2003 Nov; 23(33):10515-20. PubMed ID: 14627635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy.
    Clayton CC; Bruchas MR; Lee ML; Chavkin C
    Mol Pharmacol; 2010 Mar; 77(3):339-47. PubMed ID: 19959593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells.
    Schmidt H; Schulz S; Klutzny M; Koch T; Händel M; Höllt V
    J Neurochem; 2000 Jan; 74(1):414-22. PubMed ID: 10617147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system.
    Liu J; Dong S; Li L; Wang H; Zhao J; Zhao Y
    Cell Signal; 2019 Jun; 58():91-98. PubMed ID: 30849519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia.
    Ueda H; Inoue M; Matsumoto T
    J Neurosci; 2001 May; 21(9):2967-73. PubMed ID: 11312280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smurf2 regulates the degradation of YY1.
    Jeong HM; Lee SH; Yum J; Yeo CY; Lee KY
    Biochim Biophys Acta; 2014 Sep; 1843(9):2005-11. PubMed ID: 24803334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat mu opioid receptor.
    Wolf R; Koch T; Schulz S; Klutzny M; Schröder H; Raulf E; Bühling F; Höllt V
    Mol Pharmacol; 1999 Feb; 55(2):263-8. PubMed ID: 9927617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization.
    Koch T; Schulz S; Pfeiffer M; Klutzny M; Schröder H; Kahl E; Höllt V
    J Biol Chem; 2001 Aug; 276(33):31408-14. PubMed ID: 11359768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression.
    David D; Surendran A; Thulaseedharan JV; Nair AS
    BMC Cancer; 2018 Mar; 18(1):284. PubMed ID: 29534682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nedd8 targets ubiquitin ligase Smurf2 for neddylation and promote its degradation.
    Shu J; Liu C; Wei R; Xie P; He S; Zhang L
    Biochem Biophys Res Commun; 2016 May; 474(1):51-56. PubMed ID: 27086113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E3 ubiquitin ligase SMAD ubiquitination regulatory factor 2 negatively regulates Krüppel-like factor 5 protein.
    Du JX; Hagos EG; Nandan MO; Bialkowska AB; Yu B; Yang VW
    J Biol Chem; 2011 Nov; 286(46):40354-64. PubMed ID: 21953463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats.
    Hashimoto T; Saito Y; Yamada K; Hara N; Kirihara Y; Tsuchiya M
    Anesthesiology; 2006 Sep; 105(3):574-80. PubMed ID: 16931992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.
    Ozsoy HZ; Thakker DR; Standifer KM
    Mol Pharmacol; 2005 Aug; 68(2):447-56. PubMed ID: 15890842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation.
    Groer CE; Schmid CL; Jaeger AM; Bohn LM
    J Biol Chem; 2011 Sep; 286(36):31731-41. PubMed ID: 21757712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
    Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
    J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABIN-1 Negatively Regulates
    Zhou P; Jiang J; Yan H; Li Y; Zhao J; Wang X; Su R; Gong Z
    Mol Pharmacol; 2018 Feb; 93(2):36-48. PubMed ID: 29237725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.